Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Variability in expiratory flow requirements among oscillatory positive expiratory pressure.
Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
Subcutaneous granuloma annulare: MR imaging features in six children and literature review.
Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins.
Impact of community-based interventions on HIV knowledge, attitudes, and transmission.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Schreiber, Hans
One or more keywords matched the following items that are connected to
Schreiber, Hans
Item Type
Name
Concept
Tumor Escape
Academic Article
A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
Academic Article
Role of TGF-beta in immune-evasion of cancer.
Academic Article
Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells.
Academic Article
Immunodominance and tumor escape.
Academic Article
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
Academic Article
Bystander elimination of antigen loss variants in established tumors.
Academic Article
Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.
Academic Article
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
Academic Article
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
Grant
Immunology of Unique Tumor Specific Antigens
Search Criteria
Tumor Immune Escape